Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Osteoarthritis: Prognosis and emerging therapeutic approach for disease management. | Drug Dev Res | 2021 | 32931079 | PubTator, text mining | PubMed |
| Primary glomus tumour of the pituitary gland: diagnostic challenges of a rare and potentially aggressive neoplasm. | Virchows Arch | 2021 | 32918169 | PubTator, text mining | PubMed |
| Fatal attraction: The roles of ribosomal proteins in the viral life cycle. | Wiley Interdiscip Rev RNA | 2021 | 32657002 | PubTator, text mining | PubMed |
| Perithyroidal Salivary Gland Acinic Cell Carcinoma: Morphological and Molecular Attributes of a Unique Lesion. | Head Neck Pathol | 2021 | 32519264 | PubTator, text mining | PubMed |
| PIK3CA somatic mutation in sinonasal teratocarcinosarcoma. | Auris Nasus Larynx | 2021 | 32389511 | PubTator, text mining | PubMed |
| Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC. | J Clin Pathol | 2021 | 32385139 | PubTator, text mining | PubMed |
| Diagnostic yield and clinical impact of exome sequencing in early-onset scoliosis (EOS). | J Med Genet | 2021 | 32381727 | PubTator, text mining | PubMed |
| Turning liabilities into opportunities: Off-target based drug repurposing in cancer. | Semin Cancer Biol | 2021 | 32044472 | PubTator, text mining | PubMed |
| Current progress and future perspectives of polypharmacology : From the view of non-small cell lung cancer. | Semin Cancer Biol | 2021 | 31698087 | PubTator, text mining | PubMed |
| Targeting Discoidin Domain Receptor 2 for the Development of Disease-Modifying Osteoarthritis Drugs. | Cartilage | 2021 | 31177815 | PubTator, text mining | PubMed |
| Future directions and management of liquid biopsy in non-small cell lung cancer. | Explor Target Antitumor Ther | 2020 | 36046776 | PubTator, text mining | PubMed |
| Implementation of an NGS panel for clinical practice in paraffin-embedded tissue samples from locally advanced and metastatic melanoma patients. | Explor Target Antitumor Ther | 2020 | 36046072 | PubTator, text mining | PubMed |
| Clinicopathological characteristics and gene analysis of pulmonary granular cell tumor in three cases and a systematic review. | Transl Cancer Res | 2020 | 35117846 | PubTator, text mining | PubMed |
| Pathway-extended gene expression signatures integrate novel biomarkers that improve predictions of patient responses to kinase inhibitors. | MedComm (2020) | 2020 | 34766125 | PubTator, text mining | PubMed |
| Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications. | Adv Funct Mater | 2020 | 34093104 | PubTator, text mining | PubMed |
| Small Molecule Screen Reveals Joint Regulation of Stress Granule Formation and Lipid Droplet Biogenesis. | Front Cell Dev Biol | 2020 | 33972926 | PubTator, text mining | PubMed |
| Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology. | Rom J Morphol Embryol | 2020 | 33817704 | PubTator, text mining | PubMed |
| The Comprehensive Analyses of Genomic Variations and Assessment of TMB and PD-L1 Expression in Chinese Lung Adenosquamous Carcinoma. | Front Genet | 2020 | 33679868 | PubTator, text mining | PubMed |
| Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. | J Oncol | 2020 | 33643409 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor 1 functionally interacts with the IGF-I system in bladder cancer. | Matrix Biol Plus | 2020 | 33543020 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=54